Eloxx Pharmaceuticals 10K 2014 Annual report | ELOX Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	8th grade Avg

New words: AbbVie, Ablynx, acquistion, Adimab, affinity, Africa, aimed, Alforex, angiogenic, antibody, Arana, authoritative, autoimmune, autoimmunity, Avid, Avipep, Babb, bearing, bench, binary, binder, Bio, Biochemical, Biogen, biomedical, Biotherapy, blocking, bloom, Brassica, broadly, budgetary, cancellation, cancelled, Cape, carcinoma, channel, Chase, chimerasome, chronic, circulating, COBRA, combinatorial, Complementary, context, conventional, Coupled, cow, cutting, cytokine, Daiichi, Daiichii, deprioritized, Developmental, differential, discerning, display, DLT, domain, Dow, driven, easily, East, edge, editorial, encapsulating, Endo, endothelial, exclusive, FA, Fab, fade, FB, FC, FD, FE, fourth, Fox, frequently, Frost, functional, functionality, functionally, GAAP, Genentech, geometry, GPCR, granzyme, Graziano, Greg, Groote, healthy, Hokko, Idec, Immunogen, immunological, Immunology, immunosuppressive, implicated, indefinite, innovation, Innovative, ion, Jolla, Kirin, knob, Kraft, Kyawa, Kymab, La, Lerner, leukemia, library, lived, living, los, lump, lymphocytic, Martell, Mary, meant, mechanistic, mentioned, Merck, metastatic, Miguel, mixture, MN, modulate, modulating, molecule, Morgantown, multispanning, nanocage, Nasal, necessarily, Neupogen, neutropenia, Novimmune, NV, OPKO, opposed, ornamental, ovarian, paradigm, pathway, pattern, Pfizer, phage, Phillip, piezoelectric, pipeline, pool, poor, potent, potently, Pretoria, pro, profile, proven, Pty, purification, purified, radiolabelled, rata, rational, reaction, recombinant, Regeneron, reinvestment, renal, Reorganization, repaid, repayment, repertoire, replacement, retroactively, rheumatoid, Rochester, Rock, rotated, Rubin, SA, Sankyo, Schuur, Seattle, sensitivity, Sequenom, Sevion, shape, shareholder, signaling, simple, Smider, solid, sooner, South, spatially, SQNM, Squibb, stalk, Steven, strongest, Sublandord, subset, subtly, sum, surface, Swedish, Symphogen, Takeda, tehnology, teva, thirteen, TNFa, Tom, Town, traditional, ultralong, uncomplicated, unpurified, unusual, vascular, Vaughn, VEGF, Viventia, WV, Xencor, Xerion, YM

Removed: allocate, allocation, amortizing, applied, approximated, assisting, BCF, Binational, BIRD, Black, building, calculate, Canada, characterized, charge, clearing, combine, Condensed, conditional, CRO, CropScience, culture, cumulatively, cycle, Dean, discounted, Distinguishing, dominated, employing, enactment, ending, ensuring, facility, fertilizer, formed, germplasm, GLP, GmbH, greenhouse, hiring, improved, initiated, introduction, investigate, Israeli, issuable, listing, McNicoll, measurable, Mendel, Merton, mission, Morgan, mutual, Noncompetition, Nondisclosure, opened, partial, partnership, pivotal, productivity, prohibited, promulgated, proportion, proportionate, quality, reclassified, recovered, regain, reliably, Renessen, resultant, RSU, Ruedi, seed, sequential, settled, sharing, shifted, shipment, size, slightly, soybean, spent, ST, submitting, Syngenta, team, thereto, tissue, toxicological, transformation, transforming, undergoing, understanding, usage, venture, Vlak, whichever

/s/ John Thompson
1438120 Ontario Limited
Dr. John Thompson

Eloxx Pharmaceuticals (ELOX) 10-K2014 FY Annual report

Content analysis